Today:Early fog in the far southwest clears quickly. Most areas stay dry with sunshine and variable cloud, though northern and northeastern regions may see isolated showers. Light winds overall, ...

The MediaTek Dimensity 8550 chip was just announced with support for Gemini Intelligence. Google has set steep requirements for Android 17's marquee Gemini Intelligence feature. They rule out most ...

My pick of the best lavalier microphones for filmmakers and sound recorders – just clip them to a lapel and go! When you purchase through links on our site, we may earn an affiliate commission. Here’s ...

Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Chip Stapleton is a Series 7 and Series 66 license holder, CFA Level ...

The iPad is a capable device for both art and productivity, but it becomes a stronger proposition in both areas if you have a good stylus to hand. Whether you’re sketching a new building design, ...

With a laptop, a pair of headphones or monitors, and a MIDI keyboard, you've got everything you need to make music in the modern world. Whether your fare is trap beats or EDM bangers, you can make ...

Picture this: you’re in the middle of a video call, and your colleague shares a critical data chart or a brilliant slide on their screen. If you use a Windows PC, you already have one of the simplest, ...

The combination therapy, which adds a drug called enzalutamide [Xtandi] to commonly prescribed hormone therapy, reduced deaths in patients with recurrent prostate cancer after surgery or radiation for ...

Use Contact Key Verification to ensure the person you're texting is not an imposter. Turn on Advanced Data Protection to secure all iCloud data, including Messages. Lock the Messages app with Face ID ...

There is a lot going on in Dragon Ball: Sparking! Zero’s combat, and while there is a short tutorial at the beginning of the game to get you started, it doesn’t even go into half of the deeper ...

Rybrevant plus Lazcluze is now approved as first-line treatment for people with advanced or metastatic non-small-cell lung cancer with EGFR mutations.